Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...

Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Available by prescription (Xenical) and over the counter (Alli), it is often used with a low-fat diet. While effective, ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Rybelsus. Rybelsus is an oral form of semaglutide. It’s FDA-approved for diabetes, but (like Ozempic) it’s sometimes prescribed off-label for weight loss. Compounded semaglutide. Compounded ...

Rybelsus. Rybelsus is a daily pill FDA-approved for diabetes but sometimes prescribed off-label for weight loss. As with brand-name versions of semaglutide, there’s no magic number for how long ...

Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company highlights ...